28255317|t|The effect of Nigella sativa on inflammation - induced myocardial fibrosis in male rats
28255317|a|Nigella sativa (NS) (Ranunculaceae) used as a protective and therapeutic traditional medicine. This study evaluates the effect of NS on inflammation - induced myocardial fibrosis, serum and tissue inflammatory markers, and oxidative stress status in male rats. Fifty male Wistar rats were divided into five groups: (1) control; (2) lipopolysaccharide (LPS), 1 mg/kg/day; (3) LPS + NS (hydroalcoholic extract), 100 mg/kg/day; (4) LPS + NS, 200 mg/kg/day; (5) LPS + NS, 400 mg/kg/day (n = 10 in each group). The duration of LPS administration was two weeks. At the end of the experiment, blood samples were taken and ventricles were homogenized and stained for histological evaluation. Serum nitrite levels were lower in LPS group than the control group (22.98 ± 1.03 vs 28.5 ± 0.93 μmol/L), in which they were significantly increased by NS treatment (P < 0.05). Higher levels of heart interlukine-6 (IL-6) and tumor necrosis factor-α (TNF-α) were observed in LPS group compared to the controls (IL-6: 6805 ± 656 vs 4733 ± 691 pg/mL; TNF-α: 6504 ± 501 vs 5309 ± 452 pg/mL), in which they were reduced by NS 400 mg/kg compared to LPS groups (P < 0.05). A significant increment of malondialdehyde and reduction in heart total thiol, superoxide dismutase and catalase concentrations were observed in LPS group (p < 0.05) which significantly restored with treatment by three doses of NS. Histopathological studies showed higher inflammatory cell infiltrates, cardiac fibrosis, and collagen deposition in LPS group, which were reduced by the administration of NS. Treatment by NS reduced myocardial fibrosis in inflammation - induced fibrosis, possibly through improving oxidative / anti-oxidative balance.
28255317	4	13	effect of	T080	C1704420
28255317	14	28	Nigella sativa	T002	C1140702
28255317	32	44	inflammation	T046	C0021368
28255317	47	54	induced	T169	C0205263
28255317	55	74	myocardial fibrosis	T046	C0151654
28255317	78	82	male	T032	C0086582
28255317	83	87	rats	T015	C0086893
28255317	88	102	Nigella sativa	T002	C1140702
28255317	104	106	NS	T002	C1140702
28255317	109	122	Ranunculaceae	T002	C0446214
28255317	134	144	protective	T121	C0033613
28255317	149	160	therapeutic	T169	C0039798
28255317	161	181	traditional medicine	T091	C0025131
28255317	194	203	evaluates	T058	C0220825
28255317	208	217	effect of	T080	C1704420
28255317	218	220	NS	T002	C1140702
28255317	224	236	inflammation	T046	C0021368
28255317	239	246	induced	T169	C0205263
28255317	247	266	myocardial fibrosis	T046	C0151654
28255317	268	273	serum	T031	C0229671
28255317	278	284	tissue	T024	C0040300
28255317	285	297	inflammatory	T169	C0333348
28255317	311	327	oxidative stress	T049	C0242606
28255317	328	334	status	T080	C0449438
28255317	338	342	male	T032	C0086582
28255317	343	347	rats	T015	C0086893
28255317	355	359	male	T032	C0086582
28255317	360	371	Wistar rats	T015	C0034716
28255317	377	384	divided	T169	C0332849
28255317	395	401	groups	T078	C0441833
28255317	407	414	control	T096	C0009932
28255317	420	438	lipopolysaccharide	T109	C0023810
28255317	440	443	LPS	T109	C0023810
28255317	463	466	LPS	T109	C0023810
28255317	469	471	NS	T002	C1140702
28255317	473	495	hydroalcoholic extract	T123	C0032081
28255317	517	520	LPS	T109	C0023810
28255317	523	525	NS	T002	C1140702
28255317	546	549	LPS	T109	C0023810
28255317	552	554	NS	T002	C1140702
28255317	586	591	group	T078	C0441833
28255317	598	606	duration	T079	C0449238
28255317	610	613	LPS	T109	C0023810
28255317	614	628	administration	T058	C3469597
28255317	637	642	weeks	T079	C0439230
28255317	662	672	experiment	T062	C0205664
28255317	674	687	blood samples	T031	C0178913
28255317	703	713	ventricles	T023	C2355627
28255317	719	730	homogenized	T059	C0022885
28255317	735	742	stained	T059	C0487602
28255317	747	759	histological	T059	C0019637
28255317	760	770	evaluation	T058	C0220825
28255317	772	777	Serum	T031	C0229671
28255317	778	792	nitrite levels	T059	C0523792
28255317	798	803	lower	T052	C2003888
28255317	807	810	LPS	T109	C0023810
28255317	811	816	group	T078	C0441833
28255317	826	839	control group	T096	C0009932
28255317	911	920	increased	T081	C0205217
28255317	924	926	NS	T002	C1140702
28255317	927	936	treatment	T061	C0087111
28255317	956	985	levels of heart interlukine-6	T059	C0919829
28255317	987	991	IL-6	T059	C0919829
28255317	997	1020	tumor necrosis factor-α	T059	C1168005
28255317	1022	1027	TNF-α	T059	C1168005
28255317	1046	1049	LPS	T109	C0023810
28255317	1050	1055	group	T078	C0441833
28255317	1056	1064	compared	T052	C1707455
28255317	1072	1080	controls	T096	C0009932
28255317	1082	1086	IL-6	T059	C0919829
28255317	1120	1125	TNF-α	T059	C1168005
28255317	1179	1186	reduced	T080	C0392756
28255317	1190	1192	NS	T002	C1140702
28255317	1203	1211	compared	T052	C1707455
28255317	1215	1218	LPS	T109	C0023810
28255317	1219	1225	groups	T078	C0441833
28255317	1240	1251	significant	T078	C0750502
28255317	1252	1261	increment	T081	C1705117
28255317	1265	1280	malondialdehyde	T109,T123	C0024643
28255317	1285	1294	reduction	T080	C0392756
28255317	1298	1303	heart	T023	C0018787
28255317	1304	1309	total	T080	C0439810
28255317	1310	1315	thiol	T109	C0038734
28255317	1317	1337	superoxide dismutase	T116,T121,T126	C0038838
28255317	1342	1350	catalase	T116,T126	C0007367
28255317	1351	1365	concentrations	T081	C1446561
28255317	1383	1386	LPS	T109	C0023810
28255317	1387	1392	group	T078	C0441833
28255317	1424	1432	restored	T061	C1283255
28255317	1438	1447	treatment	T061	C0087111
28255317	1457	1462	doses	T081	C0178602
28255317	1466	1468	NS	T002	C1140702
28255317	1470	1487	Histopathological	T169	C0243140
28255317	1488	1495	studies	T062	C2603343
28255317	1503	1509	higher	T080	C0205250
28255317	1510	1539	inflammatory cell infiltrates	T031	C0541629
28255317	1541	1557	cardiac fibrosis	T047	C1397307
28255317	1563	1571	collagen	T116	C0009325
28255317	1572	1582	deposition	T169	C0333562
28255317	1586	1589	LPS	T109	C0023810
28255317	1590	1595	group	T078	C0441833
28255317	1608	1615	reduced	T080	C0392756
28255317	1623	1637	administration	T058	C3469597
28255317	1641	1643	NS	T002	C1140702
28255317	1645	1654	Treatment	T061	C0087111
28255317	1658	1660	NS	T002	C1140702
28255317	1669	1688	myocardial fibrosis	T046	C0151654
28255317	1692	1704	inflammation	T046	C0021368
28255317	1707	1714	induced	T169	C0205263
28255317	1715	1723	fibrosis	T046	C0016059
28255317	1742	1751	improving	T080	C1272745
28255317	1752	1761	oxidative	T169	C0311404
28255317	1764	1778	anti-oxidative	T033	C0243095
28255317	1779	1786	balance	T169	C0205415